ERBB2 and breast carcinoma: Despite the fact that ERBB2-positive (ERBB2+) tumors are among those with the highest EZH2 expression and H3K27 tri-methlyation10, few studies have examined the functional requirement for EZH2 specifically in ERBB2+ breast cancer.